Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (41-50 of 1,279) with videos related to

Pageof 128
Sort By:
Revista Espanola De Enfermedades Digestivas|July 1, 1997
[Predictive factors of response to interferon-alpha treatment in chronic hepatitis C]M Buti, R Esteban
Acta Bio-Medica : Atenei Parmensis|September 21, 2016
Cabozantinib in renal cell carcinoma: only a METEOR or a rising star?Melissa Bersanelli, Sebastiano Buti
Journal of Hepatology|January 6, 2000
Retreatment of interferon relapse patients with chronic hepatitis CM Buti, R Esteban
Medicina Clinica|April 24, 2004
[Cytokines and liver cirrhosis]Joan Genescà, Maria Buti
Acta Gastroenterologica Latinoamericana|January 23, 2009
[Therapy of chronic hepatitis B]María Buti, Rafael Esteban
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Triple therapy with boceprevir or telaprevir for treatment naïve HCV patientsRafael Esteban, Maria Buti
Clinics in Liver Disease|August 27, 2011
1990-2010: two decades of interferon-based therapyMaria Buti, Rafael Esteban
Gastroenterology|October 6, 2016
Hepatitis C Therapy: Game Over!Alessio Aghemo, Maria Buti
Journal of Viral Hepatitis|March 5, 2004
Does twice-weekly administration of peginterferon alfa-2b really improve viral kinetics in patients with chronic hepatitis C genotype 1?M Buti, R Esteban
Journal of Hepatology|January 8, 2004
Entecavir, FTC, L-FMAU, LdT and othersMaria Buti, Rafael Esteban
Pageof 128

Showing results (41-50 of 1,279) with videos related to

Sort By:
Pageof 128
Revista Espanola De Enfermedades Digestivas|July 1, 1997
[Predictive factors of response to interferon-alpha treatment in chronic hepatitis C]M Buti, R Esteban
Acta Bio-Medica : Atenei Parmensis|September 21, 2016
Cabozantinib in renal cell carcinoma: only a METEOR or a rising star?Melissa Bersanelli, Sebastiano Buti
Journal of Hepatology|January 6, 2000
Retreatment of interferon relapse patients with chronic hepatitis CM Buti, R Esteban
Medicina Clinica|April 24, 2004
[Cytokines and liver cirrhosis]Joan Genescà, Maria Buti
Acta Gastroenterologica Latinoamericana|January 23, 2009
[Therapy of chronic hepatitis B]María Buti, Rafael Esteban
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Triple therapy with boceprevir or telaprevir for treatment naïve HCV patientsRafael Esteban, Maria Buti
Clinics in Liver Disease|August 27, 2011
1990-2010: two decades of interferon-based therapyMaria Buti, Rafael Esteban
Gastroenterology|October 6, 2016
Hepatitis C Therapy: Game Over!Alessio Aghemo, Maria Buti
Journal of Viral Hepatitis|March 5, 2004
Does twice-weekly administration of peginterferon alfa-2b really improve viral kinetics in patients with chronic hepatitis C genotype 1?M Buti, R Esteban
Journal of Hepatology|January 8, 2004
Entecavir, FTC, L-FMAU, LdT and othersMaria Buti, Rafael Esteban
Pageof 128